Unlocking the market-back advantage
Biopharmaceutical and healthcare companies often struggle to integrate a market-back understanding into their planning processes. Without a clear grasp of market dynamics, payer priorities, and patient needs, even the most innovative products can face significant downstream challenges—misaligned strategies, portfolio inefficiencies, and barriers to market access. This misstep risks delaying patient impact and undermining the full potential of your pipeline.
Solution: Bridging Innovation and Market Realities
At Niven biopharma, we take a holistic, integrated approach to help you align your innovations with market realities. By combining deep insights into market needs, strategic portfolio management, and pathways to access, we enable you to make informed decisions at every stage. From New Product Planning that ensures your products are designed with market priorities in mind, to Porfolio Strategy that balances risk and maximizes value, to Market Access solutions that bridge the gap to patients and payers - our comprehensive approach ensures your innovations are primed for success from concept to market entry.
Milestones That Matter, Outcomes That Last
With Niven Biopharma as your partner, you can achieve critical milestones and value inflection points with confidence. Our integrated approach ensures your innovations are strategically positioned to succeed in competitive markets, driving measurable outcomes for your business. Most importantly, by aligning innovation with market and patient needs, we help you deliver transformative therapies to those who need them most—improving lives while unlocking the full potential of your pipeline.
Services
At Niven Biopharma, we specialize in New Product Planning, Portfolio Strategy, and Market Access, offering tailored support to meet your needs. Whether you require strategic advisory or hands-on project leadership, I bring the expertise and insights to drive your initiatives forward.
New Product Planning
Aligning innovation with market needs to maximise value at every milestone, whether for out licensing or self-commercialisation
Portfolio Strategy
Delivering strategic insights to prioritize assets, optimize portfolios, and drive value across development milestones
Market Access
Crafting strategic market access pathways to overcome barriers and enhance value for internal launches or partnerships
About
Doug Niven
Doug Niven has over 20 years professional experience in research, health and life science sectors. He has worked extensively with big pharma, biotechs as well as financial investors and med tech companies. During this time he has supported the development and commercialisation of over 20 different drugs/therapies.
He brings extensive experience in working across multiple therapeutic areas including rare diseases, inflammation and immunology, neurology and oncology. He has also worked on assets with different treatment modalities including small molecules, biologics, medical devices and digital therapeutics.
Biopharma over coffee blog
Check out our blog Biopharma Over Coffee in which we cover new and innovative developments in biotech, pharma and the markets. Each article perfect to read over a cup of coffee. Below are links to several recent articles.